WuXi Won’t Make Hong Kong IPOs Hot

Guotai Junan Securities Co., for example, placed about half its IPO with cornerstone investors and the Shenzhen and Shanghai governments. WuXi Biologics has an advantage in that it makes biopharmaceuticals, drugs that use live substances and that are ... ( read original story ...)

Shanghai’s blue chip rally shows no signs of fading

The rally among Shanghai blue-chips will likely continue as earnings improve, whereas the valuations of smaller-caps will remain pressured by the ongoing financial crackdown, according to Shenwan Hongyuan. “A simultaneous rise in risk-free interest rates ... ( read original story ...)

China stocks fall despite fewer IPOs, big caps weigh

The Shanghai SE 50 Index, dubbed "China's nifty 50 index", dropped 1 percent, in contrast with a gain of 0.9 percent in the tech-heavy start-up board ChiNext. The China Securities Regulatory Commission (CSRC) approved on Friday only four IPOs to raise up ... ( read original story ...)